Skip to main content
. 2017 Aug 25;7:9548. doi: 10.1038/s41598-017-10328-8

Table 1.

Correlations of PNI and clinicopathological characteristics of ovarian cancer patients.

Variable n (%) PNI P value
<47.2, n (%) ≥47.2, n (%)
Age (years) 0.066
≤50 125 (52.7) 65 (47.4) 60 (60.0)
>50 112 (47.3) 72 (52.6) 40 (40.0)
Stage <0.001
FIGO I 28 (11.8) 8 (5.8) 20 (20.0)
FIGO II 39 (16.5) 15 (10.9) 24 (24.0)
FIGO III 140 (59.1) 92 (67.2) 48 (48.0)
FIGO IV 30 (12.7) 22 (16.1) 8 (8.0)
Residual tumor mass <0.001
≤2 cm 132 (55.7) 62 (45.3) 70 (70.0)
>2 cm 105 (44.3) 75 (54.7) 30 (30.0)
Histological subtype 0.001
Serous 123 (51.9) 61 (44.5) 62 (62.0)
Non-serous 86 (36.3) 63 (45.9) 23 (23.0)
Histological grade 0.237
G1 79 (33.3) 40 (30.0) 39 (39.0)
G2 52 (21.9) 30 (21.9) 22 (22.0)
G3 88 (37.1) 56 (40.9) 32 (32.0)
Ascites <0.001
Negative 102 (43.0) 34 (24.8) 68 (68.0)
Positive 135 (57.0) 103 (75.2) 32 (32.0)
CA-125 (U/ml) <0.001
<35 26 (11.0) 5 (3.6) 21 (21.0)
≥35 183 (77.2) 117 (85.4) 66 (66.6)
Chemosensitivity <0.001
Sensitive 131 (55.3) 61 (44.5) 70 (70.0)
Resistant 106 (44.7) 76 (55.5) 30 (30.0)
CAR <0.001
<0.5 142 (59.9) 59 (43.1) 83 (83.0)
≥0.5 95 (40.1) 78 (56.9) 17 (17.0)
LMR <0.001
<3.82 132 (55.7) 106 (77.4) 26 (26.0)
≥3.82 105 (44.3) 31 (22.6) 74 (74.0)
mGPS <0.001
0 97 (40.9) 27 (19.7) 70 (70.0)
1 76 (32.1) 46 (33.6) 30 (30.0)
2 64 (27.0) 64 (46.7) 0 (0.0)
BMI (kg/m2) 0.460
<18.5 31 (13.1) 20 (14.6) 11 (11.0)
≥18.5 206 (86.9) 117 (85.4) 89 (89.0)

CAR, C-reactive protein/albumin ratio; BMI, body mass index; FIGO, Federation of Gynecologists and Obstetricians; LMR, lymphocyte/monocyte ratio; mGPS, modified Glasgow prognostic score; PNI, prognostic nutritional index.